170 related articles for article (PubMed ID: 19528638)
21. Critical role of OX40 in CD28 and CD154-independent rejection.
Demirci G; Amanullah F; Kewalaramani R; Yagita H; Strom TB; Sayegh MH; Li XC
J Immunol; 2004 Feb; 172(3):1691-8. PubMed ID: 14734751
[TBL] [Abstract][Full Text] [Related]
22. Cutting edge: CD4+CD25+ alloantigen-specific immunoregulatory cells that can prevent CD8+ T cell-mediated graft rejection: implications for anti-CD154 immunotherapy.
van Maurik Av; Herber M; Wood KJ; Jones ND
J Immunol; 2002 Nov; 169(10):5401-4. PubMed ID: 12421913
[TBL] [Abstract][Full Text] [Related]
23. Memory alloreactive B cells and alloantibodies prevent anti-CD154-mediated allograft acceptance.
Burns AM; Ma L; Li Y; Yin D; Shen J; Xu J; Chong AS
J Immunol; 2009 Feb; 182(3):1314-24. PubMed ID: 19155477
[TBL] [Abstract][Full Text] [Related]
24. Significance of T helper 17 immunity in transplantation.
Abadja F; Sarraj B; Ansari MJ
Curr Opin Organ Transplant; 2012 Feb; 17(1):8-14. PubMed ID: 22186097
[TBL] [Abstract][Full Text] [Related]
25. Early regulation of CD8 T cell alloreactivity by CD4+CD25- T cells in recipients of anti-CD154 antibody and allogeneic BMT is followed by rapid peripheral deletion of donor-reactive CD8+ T cells, precluding a role for sustained regulation.
Fehr T; Takeuchi Y; Kurtz J; Wekerle T; Sykes M
Eur J Immunol; 2005 Sep; 35(9):2679-90. PubMed ID: 16082727
[TBL] [Abstract][Full Text] [Related]
26. Allograft rejection by primed/memory CD8+ T cells is CD154 blockade resistant: therapeutic implications for sensitized transplant recipients.
Zhai Y; Meng L; Gao F; Busuttil RW; Kupiec-Weglinski JW
J Immunol; 2002 Oct; 169(8):4667-73. PubMed ID: 12370407
[TBL] [Abstract][Full Text] [Related]
27. IL-17A Is Critical for CD8+ T Effector Response in Airway Epithelial Injury After Transplantation.
Zhang R; Fang H; Chen R; Ochando JC; Ding Y; Xu J
Transplantation; 2018 Dec; 102(12):e483-e493. PubMed ID: 30211827
[TBL] [Abstract][Full Text] [Related]
28. Anti-LFA-1 induces CD8 T-cell dependent allograft tolerance and augments suppressor phenotype CD8 cells.
Plenter RJ; Grazia TJ; Coulombe MG; Nelsen MK; Lin CM; Scott Beard K; Kupfer TM; Zamora MR; Gill RG; Pietra BA
Cell Immunol; 2018 Oct; 332():101-110. PubMed ID: 30103941
[TBL] [Abstract][Full Text] [Related]
29. Unusual patterns of alloimmunity evoked by allogeneic liver parenchymal cells.
Bumgardner GL; Orosz CG
Immunol Rev; 2000 Apr; 174():260-79. PubMed ID: 10807522
[TBL] [Abstract][Full Text] [Related]
30. Immunoregulatory function of IL-27 and TGF-β1 in cardiac allograft transplantation.
Le Texier L; Thebault P; Carvalho-Gaspar M; Vignard V; Merieau E; Usal C; Cuturi MC; Wood KJ; Chiffoleau E
Transplantation; 2012 Aug; 94(3):226-33. PubMed ID: 22790384
[TBL] [Abstract][Full Text] [Related]
31. CTLA4 signals are required to optimally induce allograft tolerance with combined donor-specific transfusion and anti-CD154 monoclonal antibody treatment.
Zheng XX; Markees TG; Hancock WW; Li Y; Greiner DL; Li XC; Mordes JP; Sayegh MH; Rossini AA; Strom TB
J Immunol; 1999 Apr; 162(8):4983-90. PubMed ID: 10202046
[TBL] [Abstract][Full Text] [Related]
32. Tim-1 blockade with RMT1-10 increases T regulatory cells and prolongs the survival of high-risk corneal allografts in mice.
Tan X; Jie Y; Zhang Y; Qin Y; Xu Q; Pan Z
Exp Eye Res; 2014 May; 122():86-93. PubMed ID: 24613782
[TBL] [Abstract][Full Text] [Related]
33. The emerging role of T cell Ig mucin 1 in alloimmune responses in an experimental mouse transplant model.
Ueno T; Habicht A; Clarkson MR; Albin MJ; Yamaura K; Boenisch O; Popoola J; Wang Y; Yagita H; Akiba H; Ansari MJ; Yang J; Turka LA; Rothstein DM; Padera RF; Najafian N; Sayegh MH
J Clin Invest; 2008 Feb; 118(2):742-51. PubMed ID: 18172549
[TBL] [Abstract][Full Text] [Related]
34. TLR engagement prevents transplantation tolerance.
Chen L; Wang T; Zhou P; Ma L; Yin D; Shen J; Molinero L; Nozaki T; Phillips T; Uematsu S; Akira S; Wang CR; Fairchild RL; Alegre ML; Chong A
Am J Transplant; 2006 Oct; 6(10):2282-91. PubMed ID: 16970798
[TBL] [Abstract][Full Text] [Related]
35. Immunostimulatory Tim-1-specific antibody deprograms Tregs and prevents transplant tolerance in mice.
Degauque N; Mariat C; Kenny J; Zhang D; Gao W; Vu MD; Alexopoulos S; Oukka M; Umetsu DT; DeKruyff RH; Kuchroo V; Zheng XX; Strom TB
J Clin Invest; 2008 Feb; 118(2):735-41. PubMed ID: 18079964
[TBL] [Abstract][Full Text] [Related]
36. The role of the IL-2 pathway in costimulation blockade-resistant rejection of allografts.
Jones TR; Ha J; Williams MA; Adams AB; Durham MM; Rees PA; Cowan SR; Pearson TC; Larsen CP
J Immunol; 2002 Feb; 168(3):1123-30. PubMed ID: 11801646
[TBL] [Abstract][Full Text] [Related]
37. Modulation of costimulation by CD28 and CD154 alters the kinetics and cellular characteristics of corneal allograft rejection.
Ardjomand N; McAlister JC; Rogers NJ; Tan PH; George AJ; Larkin DF
Invest Ophthalmol Vis Sci; 2003 Sep; 44(9):3899-905. PubMed ID: 12939307
[TBL] [Abstract][Full Text] [Related]
38. Induction of transplantation tolerance by allogeneic donor-derived CD4(+)CD25(+)Foxp3(+) regulatory T cells.
Velásquez-Lopera MM; Eaton VL; Lerret NM; Correa LA; Decresce RP; García LF; Jaramillo A
Transpl Immunol; 2008 May; 19(2):127-35. PubMed ID: 18503888
[TBL] [Abstract][Full Text] [Related]
39. IFN-gamma dictates allograft fate via opposing effects on the graft and on recipient CD8 T cell responses.
Coley SM; Ford ML; Hanna SC; Wagener ME; Kirk AD; Larsen CP
J Immunol; 2009 Jan; 182(1):225-33. PubMed ID: 19109153
[TBL] [Abstract][Full Text] [Related]
40. Skin allograft maintenance in a new synchimeric model system of tolerance.
Iwakoshi NN; Markees TG; Turgeon N; Thornley T; Cuthbert A; Leif J; Phillips NE; Mordes JP; Greiner DL; Rossini AA
J Immunol; 2001 Dec; 167(11):6623-30. PubMed ID: 11714833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
